The ENTPD1 gene helps break down ATP and ADP outside cells, which keeps immune signals, inflammation, and platelet activity more balanced. If it does not work properly, these signals can become less controlled and may affect how the body handles inflammation, blood flow, and tissue stress. This gene plays an important role in how your immune system responds in everyday health and in conditions such as cancer and autoimmune disease. ENTPD1 is better known in medicine and research as CD39, especially in studies of immune based treatments.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions they can use to make molecules or regulate processes in the body. Some genes hold the directions for making proteins, the working parts of cells. Others mainly help determine when certain processes happen, where they occur, and how strongly they run. Together, genes shape how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can visit the LearnHub.
Overview
ENTPD1Gene function
What if the gene works
The ENTPD1 gene helps cells break down ATP and ADP outside the cell. This supports balanced immune signaling, platelet activity, and blood vessel function.
Risk
What if the gene does not work
Milder to more severe variants in the ENTPD1 gene can reduce how well cells clear ATP and ADP outside the cell after stress or injury. This can change cell-to-cell signaling, especially in immune cells and the lining of blood vessels.
Treatment
What does that mean for your treatment
For people with a pathogenic variant in the ENTPD1 gene, no ENTPD1-specific treatment or management approach is currently established. The ENTPD1 gene is being studied in cancer care as a marker of immune activity and as a possible drug target, often under the name CD39.
Conditions associated with ENTPD1
Gene function
What if the gene works
Your cells use the ENTPD1 gene to control certain chemical signals outside the cell. Its protein sits on the cell surface and breaks down ATP and ADP, two molecules that can act like distress or activation signals when they build up nearby. This helps explain what the ENTPD1 gene does in the immune system and blood vessels during everyday cell activity.
The ENTPD1 gene makes a protein that sits on the outside of many cells and breaks down ATP and ADP. This turns strong outside-cell signals into AMP, helping keep local communication more controlled.
Many immune cells use this protein to reduce alarm signals in their surroundings. That helps shape a steadier immune response during normal tissue monitoring and everyday healing.
In blood vessels, this protein lowers the amount of ADP available to switch platelets on. This supports smoother blood flow and keeps clotting signals better balanced.
The AMP produced by this protein can then be converted into adenosine, another signal molecule outside cells. This connects the ENTPD1 gene to a pathway that helps calm cell activity in surrounding tissues.
What is a variant?
A genetic variant is a slight change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ENTPD1 gene can alter the CD39 protein’s shape, stability, or movement to the cell surface, lowering or abolishing its enzyme activity. How ENTPD1 gene variants affect the CD39 protein depends on the change: milder variants may leave some activity, while more disruptive variants can stop the protein from working or from reaching the cell surface. When both copies carry severe variants, ENTPD1-related spastic paraplegia often starts earlier and can be more marked.
How variants are linked to conditions
Current research on how ENTPD1 gene variants are linked to conditions is still developing, and the ENTPD1 gene does not yet have a broadly confirmed link to one specific health condition. Anyone with a confirmed ENTPD1-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the ENTPD1 gene. People with questions about their personal or family risk can talk with a doctor or genetic counselor for advice that fits their situation.
Inheritance of ENTPD1 variants
For ENTPD1 gene inheritance, there is not yet a broadly confirmed disease specific inheritance pattern used in clinical genetics, and research on this gene is still developing. ENTPD1 is on chromosome 10, which is an autosome, so you inherit one copy from each parent. That means any ENTPD1 gene variant present in your DNA would come through the usual inheritance of autosomal genes rather than a sex linked pattern.
What does my ENTPD1 result mean for my family?
For ENTPD1, the best-known inherited condition follows a recessive pattern. For family members, this usually means parents can be healthy carriers, and brothers or sisters may also be carriers or, less often, have the condition. Other close relatives may carry the same gene change too, especially on the same side of the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the ENTPD1 gene, ENTPD1 genetic testing analyzes DNA from a blood or saliva sample, often as part of a larger sequencing panel. The lab reads the gene’s code and reports whether it finds a benign variant, a variant of uncertain significance, or a variant linked to disease.
When should I consider getting a genetic test?
There is not yet a widely accepted, ENTPD1-specific reason for genetic testing in routine care. Decisions about testing are usually based on your symptoms, medical history, and family history, ideally with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. How the body functions over time is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other aspects of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. The same medication may work well for one person, have less effect in another, or cause more side effects because the body can absorb, break down, transport, or respond to drugs differently. These inherited differences are common and can influence both how well a treatment works and how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies connections between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can influence both how the body processes a drug and how strong its effects are. This information can support more informed, individualized treatment choices. You can read more about this topic in the LearnHub.
Drugs influenced by the ENTPD1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted, so any concerns about treatment, side effects, or your general health are best discussed with your doctor.
History
The ENTPD1 gene came into view through studies of a cell surface protein called CD39, first described on immune cells in the late 1980s and early 1990s. In recent decades, awareness of this gene’s role has grown as researchers connected CD39 with a broader family of enzymes that handle signaling molecules outside cells. As medical science evolved, so did understanding of this gene, and CD39 was formally linked to the ENTPD1 gene and recognized as NTPDase1 in scientific naming. Work in the 1990s and 2000s helped place it within growing research on immunity, blood vessel biology, and inflammation. These historical steps shaped today’s understanding and made the ENTPD1 gene a familiar part of modern immunology research.